E Factor Experiences Ltd vs Sheel Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Mar 16, 2026

Key Highlights

The Latest Trading Price of E Factor Experiences Ltd is ₹ 184.05 as of 16 Mar 15:30 . The P/E Ratio of E Factor Experiences Ltd changed from 12 on March 2024 to 9.5 on March 2025 . This represents a CAGR of -11.02% over 2 yearsThe P/E Ratio of Sheel Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of E Factor Experiences Ltd changed from ₹ 184.93 crore on March 2024 to ₹ 191.74 crore on March 2025 . This represents a CAGR of 1.82% over 2 yearsThe Market Cap of Sheel Biotech Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of 0.0% over 5 years The Dividend Payout of E Factor Experiences Ltd changed from 24.37 % on March 2021 to 7.8 % on March 2025 . This represents a CAGR of -20.38% over 5 yearsThe Dividend Payout of Sheel Biotech Ltd changed from 28.46 % on March 2022 to 14.05 % on March 2025 . This represents a CAGR of -16.18% over 4 years .

About E Factor Experiences Ltd

E Factor Experiences Limited was originally incorporated as a Private Limited Company as 'E Factor Entertainment Private Limited' on January 02, 2003 with the RoC, Delhi & Haryana.
Subsequently, the Company's name changed from 'E Factor Entertainment Private Limited' to 'E Factor Experiences Private Limited' dated August 04, 2021.
It later, converted into a Public Limited Company and the name of the Company was changed to 'E Factor Experiences Limited' vide a fresh Certificate of Incorporation dated September 30, 2021, issued by the Registrar of Companies. The Company is an event management company engaged in providing the consumers and community with enthralling experiences, event services, technology based permanent & semi-permanent multimedia light & sound installations and specialized turnkey wedding management, design & execution solutions.

About Sheel Biotech Ltd

Sheel Biotech Limited was incorporated as a Private Company as 'Sheel Biotech Private Limited' dated November 26, 1991, with the Registrar of Companies, Delhi & Haryana.
Further, Company was converted into a Public Limited Company w.e.f.
April 02, 1992. The Company was founded by Dr. Satya Narayan Chandak in 1991.
Thereafter, through his vision he led the stone of Tissue Culture lab wherein for advancement of lab he deputed two of his scientists to Netherlands for training to expand the business ventured in domestic market too and then added greenhouse division to promote protected cultivation.
The Company started the Import division in 2019 and importing tulip, glad, lilium, orchids and alstromeria.

FAQs for the comparison of E Factor Experiences Ltd and Sheel Biotech Ltd

Which company has a larger market capitalization, E Factor Experiences Ltd or Sheel Biotech Ltd?

Market cap of E Factor Experiences Ltd is 240 Cr while Market cap of Sheel Biotech Ltd is 110 Cr

What are the key factors driving the stock performance of E Factor Experiences Ltd and Sheel Biotech Ltd?

The stock performance of E Factor Experiences Ltd and Sheel Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for E Factor Experiences Ltd and Sheel Biotech Ltd?

As of March 16, 2026, the E Factor Experiences Ltd stock price is INR ₹184.05. On the other hand, Sheel Biotech Ltd stock price is INR ₹54.45.

How do dividend payouts of E Factor Experiences Ltd and Sheel Biotech Ltd compare?

To compare the dividend payouts of E Factor Experiences Ltd and Sheel Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.